Co prescription of anti-acid therapy reduces the bio availability of mycophenolate mofetil in systemic sclerosis patients

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2021
This article has no abstract
Epistemonikos ID: ef8c4aaa9d526cb12aaa082c57d690f8fc64d634
First added on: Feb 13, 2025